Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v13-FR | Version v11-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2022-08-29 | 2022-08-04 |
| Drug Identification Number | 02439409 | 02439409 |
| Brand name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
| Common or Proper name | Ropivacaine Hydrochloride Injection, USP | Ropivacaine Hydrochloride Injection, USP |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE |
| Strength(s) | 10MG | 10MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | EPIDURAL EPIDURAL | EPIDURAL EPIDURAL |
| Packaging size | 20mL | 20mL |
| ATC code | N01BB | N01BB |
| ATC description | ANESTHETICS, LOCAL | ANESTHETICS, LOCAL |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2022-06-01 | 2022-06-01 |
| Estimated end date | 2022-08-26 | 2022-08-26 |
| Actual end date | 2022-08-26 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Effective June 1, 2022 until Aug 26, 2022 we will be encountering a supply interruption with substitution available using our 10 mg/mL 10mL Ampoule. | Effective June 1, 2022 until Aug 26, 2022 we will be encountering a supply interruption with substitution available using our 10 mg/mL 10mL Ampoule. |
| Health Canada comments |